Camlin Fine Sciences Limited conducted a group meeting with investors and analysts on July 1, 2026, in Mumbai. The interaction, which commenced at 04:00 PM IST, aimed to engage stakeholders regarding the company's performance and outlook based on publicly available information. No unpublished price-sensitive information (UPSI) was disclosed during the session.

The meeting was held pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events, including investor interactions, to ensure transparency with the stock exchanges. The company notified both BSE Limited and the National Stock Exchange of India Ltd. regarding the event.

Rahul Sawale, Company Secretary & VP Legal, confirmed the completion of the interaction in a filing dated July 1, 2026. The communication served as an update to the earlier intimation dated June 28, 2026, regarding the scheduling of the meeting.

Meeting Details

The registered office of Camlin Fine Sciences Limited is located at Floor 2 to 5, In G.S. Point, CST Road, Kalina, Santacruz (East), Mumbai 400 098.

Camlin Fine Sciences Limited has received clearance from the board of the French Stock Markets Authority (AMF) to launch a mandatory cash tender offer for the remaining shares of Vinpai. The simplified cash tender offer (OPAS) is priced at EUR 3.60 per Vinpai share, identical to the price paid during the initial block acquisition. This regulatory approval allows the company to proceed with the acquisition of shares not currently held by it.

The company completed a block acquisition on November 27, 2025, securing a 78.68% stake in Vinpai's share capital and 84.89% of voting rights. This transaction was executed via a contribution in kind at EUR 3.60 per share. Following the conversion of convertible bonds, which allowed the subscription to 1,100,000 new ordinary shares, Camlin Fine Sciences increased its holding to 83.82% of the share capital and 80.85% of the voting rights as of the current date.

The offer document and other information document detailing the legal, financial, and accounting characteristics of Camlin Fine Sciences have been made available to the public. These documents are accessible on the websites of the AMF, Camlin Fine Sciences Limited, and Vinpai. The timetable and specific terms and conditions of the OPAS are outlined within the offer document.

Transaction Details

The following table summarizes the key transaction details:

Advisors for the transaction include ALLinvest Securities as the presenting institution and FONTAINE Avocats as the legal advisor. The offer is subject to regulatory compliance and restrictions in various jurisdictions, including the United States, Australia, Canada, South Africa, and Japan.